These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22258321)

  • 1. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
    Parikh CR; Dahl NK; Chapman AB; Bost JE; Edelstein CL; Comer DM; Zeltner R; Tian X; Grantham JJ; Somlo S
    Kidney Int; 2012 Apr; 81(8):784-90. PubMed ID: 22258321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.
    Kawano H; Muto S; Ohmoto Y; Iwata F; Fujiki H; Mori T; Yan L; Horie S
    Clin Exp Nephrol; 2015 Oct; 19(5):968-73. PubMed ID: 25543187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.
    Gevers TJ; Chrispijn M; Wetzels JF; Drenth JP
    BMC Nephrol; 2012 Apr; 13():17. PubMed ID: 22475206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
    Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
    Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat.
    Han M; Li Y; Liu M; Li Y; Cong B
    BMC Nephrol; 2012 Jun; 13():25. PubMed ID: 22564340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery.
    Sprenkle PC; Wren J; Maschino AC; Feifer A; Power N; Ghoneim T; Sternberg I; Fleisher M; Russo P
    J Urol; 2013 Jul; 190(1):159-64. PubMed ID: 23391468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
    Shrestha K; Shao Z; Singh D; Dupont M; Tang WH
    Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.
    Hall IE; Yarlagadda SG; Coca SG; Wang Z; Doshi M; Devarajan P; Han WK; Marcus RJ; Parikh CR
    J Am Soc Nephrol; 2010 Jan; 21(1):189-97. PubMed ID: 19762491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.
    Bolignano D; Coppolino G; Campo S; Aloisi C; Nicocia G; Frisina N; Buemi M
    Am J Nephrol; 2007; 27(4):373-8. PubMed ID: 17570904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Levels of Urine Neutrophil Gelatinase-associated Lipocalin and Interleukin-18 in Patients With Delayed Graft Function After Kidney Transplantation.
    Cui LY; Zhu X; Yang S; Zhou JS; Zhang HX; Liu L; Zhang J
    Transplant Proc; 2015 Dec; 47(10):2846-51. PubMed ID: 26707300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Yoshioka T; Ogawa Y; Imamaki H; Kusakabe T; Ebihara K; Omata M; Satoh N; Sugawara A; Barasch J; Nakao K
    Kidney Int; 2009 Feb; 75(3):285-94. PubMed ID: 19148153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation.
    Kohei J; Ishida H; Tanabe K; Tsuchiya K; Nitta K
    Int Urol Nephrol; 2013 Aug; 45(4):1159-67. PubMed ID: 23161375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.
    Parikh CR; Coca SG; Thiessen-Philbrook H; Shlipak MG; Koyner JL; Wang Z; Edelstein CL; Devarajan P; Patel UD; Zappitelli M; Krawczeski CD; Passik CS; Swaminathan M; Garg AX;
    J Am Soc Nephrol; 2011 Sep; 22(9):1748-57. PubMed ID: 21836143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24941494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.